Get this: People with early Alzheimer's who finished a year of donanemab treatment kept seeing benefits for up to two more years—even after stopping the drug! The study found less cognitive and functional decline compared to those who never got the treatment. It’s not a cure, but the long-lasting effects are giving a lot of hope. Of course, there are risks and side effects, but this could be a game-changer for future treatments. #Health #BodyHealth #Alzheimers